Estrogen plus progestin did not reduce the risk for coronary heart disease in postmenopausal women: COMMENTARY

Crandall, Carolyn
March 2004
ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p46
Academic Journal
The article comments on a study conducted to examine the role of estrogen plus progestin in increasing or decreasing the risk of coronary heart disease (CHD) in postmenopausal women. The study provides information on additional clinical endpoints on women health. Menopausal women who choose to take Hormone Therapy are more likely to be well-educated and have lower cardiovascular risk than women who are not taking estrogen. into their counseling for women who are starting HT. Considering the current state of evidence, clinicians cannot use coronary risk factor status to predict CHD risk associated with HT use and should integrate the possibility of adverse cardiovascular consequences.


Related Articles

  • Estrogen plus progestin did not reduce the risk for coronary heart disease in postmenopausal women.  // ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p46 

    The article focuses on the effectiveness of estrogen plus progestin in decreasing or increasing the risk for coronary heart disease in postmenopausal women. 16608 postmenopausal women who were 50 to 79 years of age had an intact uterus, and had resided in the same geographic area for about 3...

  • Update on the benefits and risks of hormone replacement therapy. Wright, Letiita J.; Klanataridou, Sophia N.; Calis, Karim Anton // Formulary;Feb2002, Vol. 37 Issue 2, p78 

    Examines the risk and benefit of hormone replacement therapy in treating postmenopausal symptoms. Association of estrogen deficiency with development of hot flashes; Reduction of fracture rates; Positive effects on indicators of coronary heart disease in postmenopausal women. INSET: Abstract.

  • Hormone use and cardiovascular impact--age matters.  // Patient Care;Mar2006, Vol. 40 Issue 3, p9 

    Presents the results of studies on the link of postmenopausal hormone therapy (HT) to coronary heart disease. Benefits of early start of HT therapy on women who are near their menopausal period; Outcome of a Women's Health Initiative Study of combined estrogen and progestin therapy among...

  • WHERE DO WE CURRENTLY STAND WITH ADVICE ON HORMONE REPLACEMENT THERAPY FOR WOMEN? Bozkurt, Biykem // Methodist DeBakey Cardiovascular Journal;Dec2010, Vol. 6 Issue 4, p21 

    The article reports on the risk factors for coronary artery disease (CAD) in women, and explores the relationship between CAD and hormone replacement therapy in postmenopausal women. As reported, certain risk factors for CAD that are unique to women include postmenopausal state, hormone...

  • Hormone replacement therapy, cardiovascular risk factors and diabetes. Smith, Martin R.; Feher, Michael D. // Journal of the British Menopause Society;2000, Vol. 6 Issue 3, p94 

    The woman with type 2 diabetes mellitus is at increased risk of developing coronary heart disease at all ages compared to the nondiabetic woman, due not only to the presence of the diabetic state but also to the increased prevalence of multiple cardiovascular risk factors. This coronary risk...

  • Postmenopausal Hormone Use in Women with Acute Coronary Syndromes. Parsons, Elizabeth; Newby, L. Kristin; Bhapkar, Manjushri V.; Alexander, Karen P.; White, Harvey D.; Shah, Svati H.; Bushnell, Cheryl D.; Califf, Robert M. // Journal of Women's Health (15409996);Oct2004, Vol. 13 Issue 8, p863 

    Background: Recent trials reveal no benefit and possible harm from chronic hormone replacement therapy (HRT). Less is known about intermediate-term outcomes associated with HRT use in the setting of acute coronary syndromes (ACS). Methods: To examine the prevalence of HRT use and relationships...

  • Use of postmenopausal estrogen replacement therapy from 1981 to 1997. Csizmadi, Ilona; Benedetti, Andrea; Boivin, Jean-François; Hanley, James A.; Collet, Jean-Paul // CMAJ: Canadian Medical Association Journal;1/22/2002, Vol. 166 Issue 2, p187 

    Examines the trends in the prevalence of estrogen use by peri- and post-menopausal women in Saskatchewan from 1981 to 1997. Focus on research on the health benefits and risks of estrogen replacement therapy (ERT); Data which indicate that the prevalence of hormone use has been increasing since...

  • Postmenopausal hormone replacement: Picking up where nature leaves off. Miller, Valery // Modern Medicine;Apr94, Vol. 62 Issue 4, p34 

    Examines the potential risks and benefits of estrogen replacement therapy for menopause. Available agents and their dosages; Points to consider when choosing candidates for therapy; Problems in early menopause; Preventing osteoporosis; Coronary heart disease. INSETS: Not just for...

  • Hormone Replacement Therapy or Prophylaxis in Postmenopausal Women with Recurrent Urinary Tract Infection. Raz, Raul // Journal of Infectious Diseases;3/2/2001 Supplement 1, Vol. 183, pS74 

    Presents information on a study which examined the use of prolonged estrogen therapy in preventing urinary tract infection in postmenopausal women. Difficulties in vaginal therapy; Indications and contraindications for estrogen therapy; Commentary.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics